381 related articles for article (PubMed ID: 36242051)
21. Enhanced transdermal efficiency of curcumin-loaded peptide-modified liposomes for highly effective antipsoriatic therapy.
Yu F; Zhang Y; Yang C; Li F; Qiu B; Ding W
J Mater Chem B; 2021 Jun; 9(24):4846-4856. PubMed ID: 34047333
[TBL] [Abstract][Full Text] [Related]
22. New topical treatments for psoriasis.
Chiricozzi A; Pitocco R; Saraceno R; Nistico SP; Giunta A; Chimenti S
Expert Opin Pharmacother; 2014 Mar; 15(4):461-70. PubMed ID: 24392930
[TBL] [Abstract][Full Text] [Related]
23. What is a role of haeme oxygenase-1 in psoriasis? Current concepts of pathogenesis.
Wojas-Pelc A; Marcinkiewicz J
Int J Exp Pathol; 2007 Apr; 88(2):95-102. PubMed ID: 17408452
[TBL] [Abstract][Full Text] [Related]
24. Transdermal Delivery of Therapeutic Compounds With Nanotechnological Approaches in Psoriasis.
Li N; Qin Y; Dai D; Wang P; Shi M; Gao J; Yang J; Xiao W; Song P; Xu R
Front Bioeng Biotechnol; 2021; 9():804415. PubMed ID: 35141215
[TBL] [Abstract][Full Text] [Related]
25. Anthralin modulates the expression pattern of cytokeratins and antimicrobial peptides by psoriatic keratinocytes.
Holstein J; Fehrenbacher B; Brück J; Müller-Hermelink E; Schäfer I; Carevic M; Schittek B; Schaller M; Ghoreschi K; Eberle FC
J Dermatol Sci; 2017 Sep; 87(3):236-245. PubMed ID: 28673488
[TBL] [Abstract][Full Text] [Related]
26. Rational for statin use in psoriatic patients.
Mosiewicz J; Pietrzak A; Chodorowska G; Trojnar M; Szepietowski J; Reich K; Rizzo M
Arch Dermatol Res; 2013 Aug; 305(6):467-72. PubMed ID: 23754638
[TBL] [Abstract][Full Text] [Related]
27. Progress in novel ultradeformable vesicular drug carrier in the topical and transdermal treatment of psoriasis.
Nayak N; Somanna P; Patil AB; Radhakrishnan A
Ther Deliv; 2020 Dec; 11(12):807-819. PubMed ID: 33267650
[TBL] [Abstract][Full Text] [Related]
28. Transdermal Delivery of Indirubin-Loaded Microemulsion Gel: Preparation, Characterization and Anti-Psoriatic Activity.
He E; Li H; Li X; Wu X; Lei K; Diao Y
Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35409158
[TBL] [Abstract][Full Text] [Related]
29. Oxidative stress in the pathogenesis of psoriasis.
Zhou Q; Mrowietz U; Rostami-Yazdi M
Free Radic Biol Med; 2009 Oct; 47(7):891-905. PubMed ID: 19577640
[TBL] [Abstract][Full Text] [Related]
30. Psoriasis Trends and Practice Gaps.
Gottlieb AB; Greb JE; Goldminz AM
Dermatol Clin; 2016 Jul; 34(3):235-42. PubMed ID: 27363878
[TBL] [Abstract][Full Text] [Related]
31. Novel antipsoriatic fluidized spanlastic nanovesicles: In vitro physicochemical characterization, ex vivo cutaneous retention and exploratory clinical therapeutic efficacy.
Elmowafy E; El-Gogary RI; Ragai MH; Nasr M
Int J Pharm; 2019 Sep; 568():118556. PubMed ID: 31348982
[TBL] [Abstract][Full Text] [Related]
32. Bilirubin nanomedicine alleviates psoriatic skin inflammation by reducing oxidative stress and suppressing pathogenic signaling.
Keum H; Kim TW; Kim Y; Seo C; Son Y; Kim J; Kim D; Jung W; Whang CH; Jon S
J Control Release; 2020 Sep; 325():359-369. PubMed ID: 32681946
[TBL] [Abstract][Full Text] [Related]
33. Dithranol-loaded nanostructured lipid carrier-based gel ameliorate psoriasis in imiquimod-induced mice psoriatic plaque model.
Sathe P; Saka R; Kommineni N; Raza K; Khan W
Drug Dev Ind Pharm; 2019 May; 45(5):826-838. PubMed ID: 30764674
[TBL] [Abstract][Full Text] [Related]
34. Anti-cytokine therapy in the treatment of psoriasis.
Kupetsky EA; Mathers AR; Ferris LK
Cytokine; 2013 Mar; 61(3):704-12. PubMed ID: 23410503
[TBL] [Abstract][Full Text] [Related]
35. Reactive Oxygen Species (ROS)-Based Nanomedicine.
Yang B; Chen Y; Shi J
Chem Rev; 2019 Apr; 119(8):4881-4985. PubMed ID: 30973011
[TBL] [Abstract][Full Text] [Related]
36. [Psoriasis--clinical picture and current therapy].
Shakery K; Reich K
Med Monatsschr Pharm; 2009 Sep; 32(9):335-44; quiz 345-6. PubMed ID: 19795696
[TBL] [Abstract][Full Text] [Related]
37. Nanocarriers Mediated Topical Drug Delivery for Psoriasis Treatment.
Gungor S; Rezigue M
Curr Drug Metab; 2017; 18(5):454-468. PubMed ID: 28228078
[TBL] [Abstract][Full Text] [Related]
38. Oxidative stress and its role in skin disease.
Trouba KJ; Hamadeh HK; Amin RP; Germolec DR
Antioxid Redox Signal; 2002 Aug; 4(4):665-73. PubMed ID: 12230879
[TBL] [Abstract][Full Text] [Related]
39. Zinc finger protein A20 is involved in the antipsoriatic effect of calcipotriol.
Liu X; Liu Y; Xu M; Li J; Teng X; Cheng H; Xia Y
Br J Dermatol; 2016 Aug; 175(2):314-24. PubMed ID: 26875609
[TBL] [Abstract][Full Text] [Related]
40. Microneedle Patch Delivery of Methotrexate-Loaded Albumin Nanoparticles to Immune Cells Achieves a Potent Antipsoriatic Effect.
Wang H; Zhao Z; Wu C; Tong X; Shi Y; Chen S
Int J Nanomedicine; 2022; 17():3841-3851. PubMed ID: 36072960
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
